BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7620161)

  • 1. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.
    Falanga A; Iacoviello L; Evangelista V; Belotti D; Consonni R; D'Orazio A; Robba L; Donati MB; Barbui T
    Blood; 1995 Aug; 86(3):1072-81. PubMed ID: 7620161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.
    De Stefano V; Teofili L; Sica S; Mastrangelo S; Di Mario A; Rutella S; Salutari P; Rumi C; d'Onofrio G; Leone G
    Blood; 1995 Nov; 86(9):3535-41. PubMed ID: 7579461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
    Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
    Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
    Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
    J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
    Falanga A; Consonni R; Marchetti M; Mielicki WP; Rambaldi A; Lanotte M; Gordon SG; Barbui T
    Leukemia; 1994 Jan; 8(1):156-9. PubMed ID: 8289480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
    Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
    Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
    Guo W; Wang H; Zhao W
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4).
    Falanga A; Marchetti M; Giovanelli S; Barbui T
    Blood; 1996 Jan; 87(2):613-7. PubMed ID: 8555483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents.
    Zhu J; Guo WM; Yao YY; Zhao WL; Pan L; Cai X; Ju B; Sun GL; Wang HL; Chen SJ; Chen GQ; Caen J; Chen Z; Wang ZY
    Leukemia; 1999 Jul; 13(7):1062-70. PubMed ID: 10400422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of von Willebrand factor in the hemostatic defect of acute promyelocytic leukemia.
    Federici AB; D'Amico EA
    Leuk Lymphoma; 1998 Nov; 31(5-6):491-9. PubMed ID: 9922039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
    Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
    Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.
    Falanga A; Consonni R; Marchetti M; Locatelli G; Garattini E; Passerini CG; Gordon SG; Barbui T
    Blood; 1998 Jul; 92(1):143-51. PubMed ID: 9639510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
    Wu F; Wang X; Zhao W; Wang H; Shen Z
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia.
    Kawai Y; Watanabe K; Kizaki M; Murata M; Kamata T; Uchida H; Moriki T; Yokoyama K; Tokuhira M; Nakajima H
    Am J Hematol; 1994 Jul; 46(3):184-8. PubMed ID: 8192147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
    Tallman MS; Hakimian D; Kwaan HC; Rickles FR
    Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia.
    Zhou J; Shi J; Hou J; Cao F; Zhang Y; Rasmussen JT; Heegaard CW; Gilbert GE
    J Thromb Haemost; 2010 Apr; 8(4):773-82. PubMed ID: 20102487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.